Global Bacteriophage Therapy Market Growth (Status and Outlook) 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Bacteriophage Therapy will have significant change from previous year. By the most conservative estimates of global Bacteriophage Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Bacteriophage Therapy market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophage Therapy market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Bacteriophage Therapy, covering the supply chain analysis, impact assessment to the Bacteriophage Therapy market size growth rate in several scenarios, and the measures to be undertaken by Bacteriophage Therapy companies in response to the COVID-19 epidemic.
Segmentation by route of administration: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Oral
Topical
Parenteral
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Armata Pharmaceuticals, Inc.
Eligo Bioscience SA
Eliava Biopreparations Ltd.
Intralytix, Inc.
Phagelux Inc.
Pherecydes Pharma
Locus Biosciences, Inc.
Nextbiotics
TechnoPhage
InnoPhage, Ltd
BiomX Ltd.
Fixed-phage Ltd.
Phi Therapeutics
Phagomed Biopharma GmbH.
EnBiotix, Inc.
Adaptive Phage Therapeutics, Inc.
ContraFect Corporation
Intodeworld, Inc.
PhagePro, Inc.
Micreos BV
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Bacteriophage Therapy market size by key regions/countries, route of administration and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Bacteriophage Therapy market by identifying its various subsegments.
Focuses on the key global Bacteriophage Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Bacteriophage Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Bacteriophage Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Bacteriophage Therapy?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Bacteriophage Therapy Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bacteriophage Therapy Market Size 2015-2025
2.1.2 Bacteriophage Therapy Market Size CAGR by Region
2.2 Bacteriophage Therapy Segment by Route of Administration
2.2.1 Oral
2.2.2 Oral
2.2.3 Parenteral
2.3 Bacteriophage Therapy Market Size by Route of Administration
2.3.1 Global Bacteriophage Therapy Market Size Market Share by Route of Administration (2015-2020)
2.3.2 Global Bacteriophage Therapy Market Size Growth Rate by Route of Administration (2015-2020)
2.4 Bacteriophage Therapy Segment by Application
2.4.1 Organ Transplantation
2.4.2 Bacterial Infections
2.4.3 Alcoholic Hepatitis
2.4.4 Other
2.5 Bacteriophage Therapy Market Size by Application
2.5.1 Global Bacteriophage Therapy Market Size Market Share by Application (2015-2020)
2.5.2 Global Bacteriophage Therapy Market Size Growth Rate by Application (2015-2020)
3 Global Bacteriophage Therapy by Players
3.1 Global Bacteriophage Therapy Market Size Market Share by Players
3.1.1 Global Bacteriophage Therapy Market Size by Players (2018-2020)
3.1.2 Global Bacteriophage Therapy Market Size Market Share by Players (2018-2020)
3.2 Global Bacteriophage Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bacteriophage Therapy by Regions
4.1 Bacteriophage Therapy Market Size by Regions
4.2 Americas Bacteriophage Therapy Market Size Growth
4.3 APAC Bacteriophage Therapy Market Size Growth
4.4 Europe Bacteriophage Therapy Market Size Growth
4.5 Middle East & Africa Bacteriophage Therapy Market Size Growth
5 Americas
5.1 Americas Bacteriophage Therapy Market Size by Countries
5.2 Americas Bacteriophage Therapy Market Size by Route of Administration
5.3 Americas Bacteriophage Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Bacteriophage Therapy Market Size by Regions
6.2 APAC Bacteriophage Therapy Market Size by Route of Administration
6.3 APAC Bacteriophage Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Bacteriophage Therapy by Countries
7.2 Europe Bacteriophage Therapy Market Size by Route of Administration
7.3 Europe Bacteriophage Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Bacteriophage Therapy by Countries
8.2 Middle East & Africa Bacteriophage Therapy Market Size by Route of Administration
8.3 Middle East & Africa Bacteriophage Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Bacteriophage Therapy Market Forecast
10.1 Global Bacteriophage Therapy Market Size Forecast (2021-2025)
10.2 Global Bacteriophage Therapy Forecast by Regions
10.2.1 Global Bacteriophage Therapy Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Bacteriophage Therapy Forecast by Route of Administration
10.8 Global Bacteriophage Therapy Forecast by Application
11 Key Players Analysis
11.1 Armata Pharmaceuticals, Inc.
11.1.1 Company Details
11.1.2 Bacteriophage Therapy Product Offered
11.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Armata Pharmaceuticals, Inc. News
11.2 Eligo Bioscience SA
11.2.1 Company Details
11.2.2 Bacteriophage Therapy Product Offered
11.2.3 Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Eligo Bioscience SA News
11.3 Eliava Biopreparations Ltd.
11.3.1 Company Details
11.3.2 Bacteriophage Therapy Product Offered
11.3.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Eliava Biopreparations Ltd. News
11.4 Intralytix, Inc.
11.4.1 Company Details
11.4.2 Bacteriophage Therapy Product Offered
11.4.3 Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Intralytix, Inc. News
11.5 Phagelux Inc.
11.5.1 Company Details
11.5.2 Bacteriophage Therapy Product Offered
11.5.3 Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Phagelux Inc. News
11.6 Pherecydes Pharma
11.6.1 Company Details
11.6.2 Bacteriophage Therapy Product Offered
11.6.3 Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Pherecydes Pharma News
11.7 Locus Biosciences, Inc.
11.7.1 Company Details
11.7.2 Bacteriophage Therapy Product Offered
11.7.3 Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Locus Biosciences, Inc. News
11.8 Nextbiotics
11.8.1 Company Details
11.8.2 Bacteriophage Therapy Product Offered
11.8.3 Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Nextbiotics News
11.9 TechnoPhage
11.9.1 Company Details
11.9.2 Bacteriophage Therapy Product Offered
11.9.3 TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 TechnoPhage News
11.10 InnoPhage, Ltd
11.10.1 Company Details
11.10.2 Bacteriophage Therapy Product Offered
11.10.3 InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 InnoPhage, Ltd News
11.11 BiomX Ltd.
11.12 Fixed-phage Ltd.
11.13 Phi Therapeutics
11.14 Phagomed Biopharma GmbH.
11.15 EnBiotix, Inc.
11.16 Adaptive Phage Therapeutics, Inc.
11.17 ContraFect Corporation
11.18 Intodeworld, Inc.
11.19 PhagePro, Inc.
11.20 Micreos BV
12 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Bacteriophage Therapy Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Bacteriophage Therapy Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Bacteriophage Therapy Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Oral
Table 7. Major Players of Topical
Table 8. Major Players of Parenteral
Table 9. Bacteriophage Therapy Market Size by Route of Administration (2014-2019) ($ Millions)
Table 10. Global Bacteriophage Therapy Market Size Market Share by Route of Administration (2015-2020)
Table 11. Global Bacteriophage Therapy Market Size by Application (2015-2020) ($ Millions)
Table 12. Global Bacteriophage Therapy Market Size Market Share by Application (2015-2020)
Table 13. Global Bacteriophage Therapy Revenue by Players (2018-2020) ($ Millions)
Table 14. Global Bacteriophage Therapy Revenue Market Share by Players (2018-2020)
Table 15. Global Bacteriophage Therapy Key Players Head office and Products Offered
Table 16. Bacteriophage Therapy Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Bacteriophage Therapy Market Size by Regions 2015-2020 ($ Millions)
Table 20. Global Bacteriophage Therapy Market Size Market Share by Regions 2015-2020
Table 21. Americas Bacteriophage Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 22. Americas Bacteriophage Therapy Market Size Market Share by Countries (2015-2020)
Table 23. Americas Bacteriophage Therapy Market Size by Route of Administration (2015-2020) ($ Millions)
Table 24. Americas Bacteriophage Therapy Market Size Market Share by Route of Administration (2015-2020)
Table 25. Americas Bacteriophage Therapy Market Size by Application (2015-2020) ($ Millions)
Table 26. Americas Bacteriophage Therapy Market Size Market Share by Application (2015-2020)
Table 27. APAC Bacteriophage Therapy Market Size by Regions (2015-2020) ($ Millions)
Table 28. APAC Bacteriophage Therapy Market Size Market Share by Regions (2015-2020)
Table 29. APAC Bacteriophage Therapy Market Size by Route of Administration (2015-2020) ($ Millions)
Table 30. APAC Bacteriophage Therapy Market Size Market Share by Route of Administration (2015-2020)
Table 31. APAC Bacteriophage Therapy Market Size by Application (2015-2020) ($ Millions)
Table 32. APAC Bacteriophage Therapy Market Size Market Share by Application (2015-2020)
Table 33. Europe Bacteriophage Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 34. Europe Bacteriophage Therapy Market Size Market Share by Countries (2015-2020)
Table 35. Europe Bacteriophage Therapy Market Size by Route of Administration (2015-2020) ($ Millions)
Table 36. Europe Bacteriophage Therapy Market Size Market Share by Route of Administration (2015-2020)
Table 37. Europe Bacteriophage Therapy Market Size by Application (2015-2020) ($ Millions)
Table 38. Europe Bacteriophage Therapy Market Size Market Share by Application (2015-2020)
Table 39. Middle East & Africa Bacteriophage Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 40. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Countries (2015-2020)
Table 41. Middle East & Africa Bacteriophage Therapy Market Size by Route of Administration (2015-2020) ($ Millions)
Table 42. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Route of Administration (2015-2020)
Table 43. Middle East & Africa Bacteriophage Therapy Market Size by Application (2015-2020) ($ Millions)
Table 44. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Application (2015-2020)
Table 45. Key and Potential Regions of Bacteriophage Therapy
Table 46. Key Application and Potential Industries of Bacteriophage Therapy
Table 47. Key Challenges of Bacteriophage Therapy
Table 48. Key Trends of Bacteriophage Therapy
Table 49. Global Bacteriophage Therapy Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 50. Global Bacteriophage Therapy Market Size Market Share Forecast by Regions
Table 51. Global Bacteriophage Therapy Market Size Forecast by Route of Administration (2021-2025) ($ Millions)
Table 52. Global Bacteriophage Therapy Market Size Market Share Forecast by Route of Administration (2021-2025)
Table 53. Global Bacteriophage Therapy Market Size Forecast by Application (2021-2025) ($ Millions)
Table 54. Global Bacteriophage Therapy Market Size Market Share Forecast by Application (2021-2025)
Table 55. Armata Pharmaceuticals, Inc. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 56. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Offered
Table 57. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue and Gross Margin (2018-2020E)
Table 58. Armata Pharmaceuticals, Inc. Main Business
Table 59. Armata Pharmaceuticals, Inc. Latest Developments
Table 60. Eligo Bioscience SA Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 61. Eligo Bioscience SA Bacteriophage Therapy Product Offered
Table 62. Eligo Bioscience SA Main Business
Table 63. Eligo Bioscience SA Bacteriophage Therapy Revenue and Gross Margin (2018-2020E)
Table 64. Eligo Bioscience SA Latest Developments
Table 65. Eliava Biopreparations Ltd. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 66. Eliava Biopreparations Ltd. Bacteriophage Therapy Product Offered
Table 67. Eliava Biopreparations Ltd. Main Business
Table 68. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue and Gross Margin (2018-2020E)
Table 69. Eliava Biopreparations Ltd. Latest Developments
Table 70. Intralytix, Inc. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 71. Intralytix, Inc. Bacteriophage Therapy Product Offered
Table 72. Intralytix, Inc. Main Business
Table 73. Intralytix, Inc. Bacteriophage Therapy Revenue and Gross Margin (2018-2020E)
Table 74. Intralytix, Inc. Latest Developments
Table 75. Phagelux Inc. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 76. Phagelux Inc. Bacteriophage Therapy Product Offered
Table 77. Phagelux Inc. Main Business
Table 78. Phagelux Inc. Bacteriophage Therapy Revenue and Gross Margin (2018-2020E)
Table 79. Phagelux Inc. Latest Developments
Table 80. Pherecydes Pharma Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 81. Pherecydes Pharma Bacteriophage Therapy Product Offered
Table 82. Pherecydes Pharma Main Business
Table 83. Pherecydes Pharma Bacteriophage Therapy Revenue and Gross Margin (2018-2020E)
Table 84. Pherecydes Pharma Latest Developments
Table 85. Locus Biosciences, Inc. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 86. Locus Biosciences, Inc. Bacteriophage Therapy Product Offered
Table 87. Locus Biosciences, Inc. Main Business
Table 88. Locus Biosciences, Inc. Bacteriophage Therapy Revenue and Gross Margin (2018-2020E)
Table 89. Locus Biosciences, Inc. Latest Developments
Table 90. Nextbiotics Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 91. Nextbiotics Bacteriophage Therapy Product Offered
Table 92. Nextbiotics Main Business
Table 93. Nextbiotics Bacteriophage Therapy Revenue and Gross Margin (2018-2020E)
Table 94. Nextbiotics Latest Developments
Table 95. TechnoPhage Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 96. TechnoPhage Bacteriophage Therapy Product Offered
Table 97. TechnoPhage Main Business
Table 98. TechnoPhage Bacteriophage Therapy Revenue and Gross Margin (2018-2020E)
Table 99. TechnoPhage Latest Developments
Table 100. InnoPhage, Ltd Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 101. InnoPhage, Ltd Bacteriophage Therapy Product Offered
Table 102. InnoPhage, Ltd Main Business
Table 103. InnoPhage, Ltd Bacteriophage Therapy Revenue and Gross Margin (2018-2020E)
Table 104. InnoPhage, Ltd Latest Developments
Table 105. BiomX Ltd. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 106. Fixed-phage Ltd. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 107. Phi Therapeutics Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 108. Phagomed Biopharma GmbH. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 109. EnBiotix, Inc. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 110. Adaptive Phage Therapeutics, Inc. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 111. ContraFect Corporation Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 112. Intodeworld, Inc. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 113. PhagePro, Inc. Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
Table 114. Micreos BV Details, Company Total Revenue (in $ million), Head Office, Bacteriophage Therapy Major Market Areas and Its Competitors
List of Figures
Figure 1. Bacteriophage Therapy Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Bacteriophage Therapy Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Bacteriophage Therapy Market Size Market Share by Route of Administration (2015-2020)
Figure 5. Global Oral Market Size Growth Rate
Figure 6. Global Topical Market Size Growth Rate
Figure 7. Global Parenteral Market Size Growth Rate
Figure 8. Bacteriophage Therapy in Organ Transplantation
Figure 9. Global Bacteriophage Therapy Market: Organ Transplantation (2015-2020) ($ Millions)
Figure 10. Bacteriophage Therapy in Bacterial Infections
Figure 11. Global Bacteriophage Therapy Market: Bacterial Infections (2015-2020) ($ Millions)
Figure 12. Bacteriophage Therapy in Alcoholic Hepatitis
Figure 13. Global Bacteriophage Therapy Market: Alcoholic Hepatitis (2015-2020) ($ Millions)
Figure 14. Global Alcoholic Hepatitis YoY Growth ($ Millions)
Figure 15. Bacteriophage Therapy in Other
Figure 16. Global Bacteriophage Therapy Market: Other (2015-2020) ($ Millions)
Figure 17. Global Other YoY Growth ($ Millions)
Figure 18. Global Bacteriophage Therapy Market Size Market Share by Application in 2019
Figure 19. Global Bacteriophage Therapy Market Size Market Share by Regions 2015-2020
Figure 20. Americas Bacteriophage Therapy Market Size 2015-2020 ($ Millions)
Figure 21. APAC Bacteriophage Therapy Market Size 2015-2020 ($ Millions)
Figure 22. Europe Bacteriophage Therapy Market Size 2015-2020 ($ Millions)
Figure 23. Middle East & Africa Bacteriophage Therapy Market Size 2015-2020 ($ Millions)
Figure 24. Americas Bacteriophage Therapy Market Size Market Share by Countries in 2019
Figure 25. Americas Bacteriophage Therapy Market Size Market Share by Route of Administration in 2019
Figure 26. Americas Bacteriophage Therapy Market Size Market Share by Application in 2019
Figure 27. United States Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 28. Canada Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 29. Mexico Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 30. APAC Bacteriophage Therapy Market Size Market Share by Regions in 2019
Figure 31. APAC Bacteriophage Therapy Market Size Market Share by Route of Administration in 2019
Figure 32. APAC Bacteriophage Therapy Market Size Market Share by Application in 2019
Figure 33. China Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 34. Japan Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 35. Korea Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 36. Southeast Asia Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 37. India Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 38. Australia Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 39. Europe Bacteriophage Therapy Market Size Market Share by Countries in 2019
Figure 40. Europe Bacteriophage Therapy Market Size Market Share by Route of Administration in 2019
Figure 41. Europe Bacteriophage Therapy Market Size Market Share by Application in 2019
Figure 42. Germany Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 43. France Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 44. UK Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 45. Italy Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 46. Russia Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 47. Spain Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 48. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Countries in 2019
Figure 49. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Route of Administration in 2019
Figure 50. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Application in 2019
Figure 51. Egypt Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 52. South Africa Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 53. Israel Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 54. Turkey Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 55. GCC Countries Bacteriophage Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 56. Global Bacteriophage Therapy arket Size Forecast (2021-2025) ($ Millions)
Figure 57. Americas Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 58. APAC Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 59. Europe Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 60. Middle East & Africa Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 61. United States Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 62. Canada Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 63. Mexico Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 64. Brazil Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 65. China Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 66. Japan Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 67. Korea Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 68. Southeast Asia Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 69. India Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 70. Australia Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 71. Germany Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 72. France Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 73. UK Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 74. Italy Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 75. Russia Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 76. Spain Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 77. Egypt Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 78. South Africa Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 79. Israel Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 80. Turkey Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
Figure 81. GCC Countries Bacteriophage Therapy Market Size 2021-2025 ($ Millions)
